glp 1 patents June 2024 Patent Highlights: GLP-1R Agonists, Polθ Inhibitors, Non-Ab PD-L1 Inhibitors, and More! Novo Nordisk sues Hims for
Description
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
It matched patients treated with GLP-1RAs with those who did not use the medication and found that GLP-1RAs were associated with a significantly lower risk of DR, with a hazard ratio (HR) of 0.42
[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Fineman M, Flanagan S, Taylor K, et al
Peer-reviewed publications, data-sharing initiatives, and interdisciplinary symposia facilitate knowledge dissemination and foster a culture of continuous learning
